Review of registered clinical trials for the treatment of COVID‐19
Abstract Coronavirus disease 2019 (COVID‐19) is a viral disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …
[HTML][HTML] Current COVID-19 treatments: Rapid review of the literature
Y Dong, A Shamsuddin, H Campbell… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background As SARS-CoV-2 continues to spread worldwide, it has already resulted in over
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
[HTML][HTML] Medical management of COVID-19: evidence and experience
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
[HTML][HTML] Pharmacologicaltreatment of COVID-19: lights and shadows
F Menzella, M Biava, C Barbieri, F Livrieri… - Drugs in …, 2020 - ncbi.nlm.nih.gov
At the end of December 2019, a novel coronavirus, the severe acute respiratory syndrome
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …
World Health Organization (WHO) therefore endorses supportive care only. However …
Management of COVID-19: A brief overview of the various treatment strategies
B Qayyumi, A Singh, V Tuljapurkar… - Cancer Research …, 2020 - journals.lww.com
Background: Coronavirus disease 2019 (COVID-19) has posed a new challenge to the
entire world. Many speculations revolve around its treatment. Numerous theories have been …
entire world. Many speculations revolve around its treatment. Numerous theories have been …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
Current pharmacological treatments for SARS-COV-2: A narrative review
G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …
November 2019, quickly spread around the world becoming a pandemic. Despite the …
[HTML][HTML] Potential treatment options for COVID-19: a comprehensive review of global pharmacological development efforts
Abstract Coronavirus disease-2019 (COVID-19), first reported in China during December of
2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020
Coronaviruses are a group of enveloped viruses with non-segmented, single-stranded, and
positive-sense RNA genomes. In December 2019, an outbreak of coronavirus disease 2019 …
positive-sense RNA genomes. In December 2019, an outbreak of coronavirus disease 2019 …